BSD Medical: Hyperthermia System for Cancer Treatment Installed At Lankenau Hospital

SALT LAKE CITY, Nov. 20, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today reported that the Lankenau Hospital Department of Radiation Oncology has become the first hospital in the Philadelphia region and the 17th nationwide (in the past 24 months) to acquire the BSD-500 Hyperthermia System for use in the treatment of cancer. The addition of the system significantly adds to the multidisciplinary arsenal of cancer treatment options Lankenau provides to the Philadelphia and Main Line community.